World Journal of Pharmaceutical
Science and Research

A Global Platform for Open Access, Peer-Reviewed, and Indexed Research in the
Pharmaceutical and Medical Sciences


Login | Registration


ISSN: 2583-6579


Impact Factor: 6.916

ABSTRACT

IN-SILICO AND DOCKING STUDIES OF DIHYDROARTEMISININ DERIVATIVES FOR ANTIMALARIAL ACTIVITY

Trivedi Gourav*, Mandloi Nilesh, Patidar Bhoopendra, Deshmukh Nitin, Karma Aman

One of the most dangerous and pervasive parasitic diseases in the under developed world is still malaria. In 2022, there was 241 million malaria cases and 6,27,000 deaths were reported worldwide. In present work 80 compounds were designed using dihydroartemisinin as a pharmacophore. In-silico studies like Lipinski Rule of Five, Molinspiration and PreADMET were performed using online available tools. To reveal the ligand - protein binding affinity designed compounds were docked on PDB: 1AJ0 (Dihydropteroate Synthase) using docking software Molegro Virtual Docker. Compound D74 showed strong bonding interaction with GLY29, GLY32, THR97, GLY99, PHE100, THR101 and ASN140 amino acids with high hydrogen bond affinity and best Moldock score-16.9698 and - 204.1319 respectively.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our IMPACT FACTOR has increased from 3.454 to 5.111

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    January 2026 Issue Now Available

    January 2026 Issue is now available online for readers and contributors. Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Upcoming Issue (2026)

    The journal invites researchers, academicians, and scholars to submit their original research articles, review papers, and case studies for the upcoming January 2026 Issue . All submissions will undergo a standard peer-review process.